Immunotherapy for Hepatocellular Carcinoma: Is Latin America Ready for Primetime?
Journal
Clinical liver disease
ISSN: 2046-2484
Titre abrégé: Clin Liver Dis (Hoboken)
Pays: United States
ID NLM: 101597441
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
14
10
2019
accepted:
08
01
2020
entrez:
2
10
2020
pubmed:
3
10
2020
medline:
3
10
2020
Statut:
epublish
Résumé
Watch a video presentation of this article.
Identifiants
pubmed: 33005389
doi: 10.1002/cld.919
pii: CLD919
pmc: PMC7508785
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
96-100Informations de copyright
© 2020 by the American Association for the Study of Liver Diseases.
Références
Lancet. 2017 Jun 24;389(10088):2492-2502
pubmed: 28434648
Lancet Oncol. 2018 Jul;19(7):940-952
pubmed: 29875066
J Hepatol. 2017 Mar;66(3):545-551
pubmed: 27816492
Lancet. 2018 Mar 31;391(10127):1301-1314
pubmed: 29307467
Nat Immunol. 2018 Mar;19(3):222-232
pubmed: 29379119
N Engl J Med. 2019 Apr 11;380(15):1450-1462
pubmed: 30970190
Gastroenterology. 2017 Sep;153(3):812-826
pubmed: 28624577
J Hepatol. 2015 Jun;62(6):1420-9
pubmed: 25733155
Immunotherapy. 2012 Nov;4(11):1081-5
pubmed: 23194355
J Hepatol. 2013 Jul;59(1):81-8
pubmed: 23466307
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373